[Federal Register Volume 91, Number 147 (Monday, August 3, 2026)]
[Notices]
[Pages 48953-48954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-15631]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on August 17, 2026, to discuss and provide recommendations from
the subcommittee on Regulatory Guide 8.39, ``Release of Patients
Administered Radioactive Material'' review of proposed patient release
revisions in the Reforming and Modernizing the NRC's Radiation
Protection Framework proposed rulemaking and draft revisions to
Regulatory Guide 8.39. Meeting information, including a copy of the
agenda and handouts, will be available on the ACMUI's Meetings and
Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026 or by
[[Page 48954]]
emailing Ms. Sarah Hoenig at the contact information below.
DATES:
Date and Time for Open Session: August 17, 2026, from 2:30 p.m. to
4:30 p.m. EST.
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
August 17, 2026................... Link: https://teams.microsoft.com/meet/26121850805993?p=ShpIU5y6zoCOpaIpVF
.
Meeting ID: 261 218 508 059 93.
Passcode: eq3se9fs.
Call in number (audio only): +1 301-
576-2978, United States, Silver
Spring.
Phone conference ID: 871 786 031#.
------------------------------------------------------------------------
Public Participation: Any member of the public who wishes to
participate in the meeting via Microsoft Teams or via phone should
contact Ms. Sarah Hoenig using the information below.
FOR FURTHER INFORMATION CONTACT: Ms. Sarah Hoenig, email:
[email protected] phone: 301-415-3284.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss recommendations from the subcommittee on
Regulatory Guide 8.39, ``Release of Patients Administered Radioactive
Material'' review of proposed patient release revisions in the
Reforming and Modernizing the NRC's Radiation Protection Framework
proposed rulemaking and draft revisions to Regulatory Guide 8.39.
Conduct of the Meeting
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the
meeting. Dr. Jadvar will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Sarah Hoenig using the contact information
listed above. All submittals must be received by the close of business
on August 12, 2026, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026 on or about September 17, 2026.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Sarah Hoenig of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 30th day of July 2026.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-15631 Filed 7-31-26; 8:45 am]
BILLING CODE 7590-01-P